GSK-3 and Tau: a key duet in Alzheimer's disease

CL Sayas, J Ávila - Cells, 2021 - mdpi.com
Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine kinase
with a plethora of substrates. As a modulator of several cellular processes, GSK-3 has a …

Tau oligomers neurotoxicity

G Niewiadomska, W Niewiadomski, M Steczkowska… - Life, 2021 - mdpi.com
Although the mechanisms of toxic activity of tau are not fully recognized, it is supposed that
the tau toxicity is related rather not to insoluble tau aggregates but to its intermediate forms. It …

Extracellular monomeric tau is internalized by astrocytes

JR Perea, E López, JC Díez-Ballesteros… - Frontiers in …, 2019 - frontiersin.org
Tau is a microtubule-associated protein that is expressed in neurons. However, in a group of
neurodegenerative diseases named tauopathies–characterized by an increase in …

Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study

Y Ivashko-Pachima, A Hadar, I Grigg, V Korenková… - Molecular …, 2021 - nature.com
With Alzheimer's disease (AD) exhibiting reduced ability of neural stem cell renewal, we
hypothesized that de novo mutations controlling embryonic development, in the form of brain …

The role of microglia in the spread of tau: relevance for tauopathies

JR Perea, M Llorens-Martín, J Ávila… - Frontiers in cellular …, 2018 - frontiersin.org
Tauopathies are neurodegenerative diseases which course with the accumulation of Tau,
mainly in neurons. In addition, Tau accumulates in a hyperphosphorylated and aggregated …

Presynaptic failure in Alzheimer's disease

G Barthet, C Mulle - Progress in neurobiology, 2020 - Elsevier
Synaptic loss is the best correlate of cognitive deficits in Alzheimer's disease (AD). Extensive
experimental evidence also indicates alterations of synaptic properties at the early stages of …

Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway

JR Perea, J Ávila, M Bolós - Experimental Neurology, 2018 - Elsevier
Tauopathies are a broad set of neurodegenerative dementias characterized by the
aggregation of Tau protein. Activated microglia and elevated levels of pro-inflammatory …

Pathological impact of tau proteolytical process on neuronal and mitochondrial function: a crucial role in alzheimer's disease

MA Olesen, RA Quintanilla - Molecular Neurobiology, 2023 - Springer
Tau protein plays a pivotal role in the central nervous system (CNS), participating in
microtubule stability, axonal transport, and synaptic communication. Research interest has …

Hippocampal neurogenesis and pro‐neurogenic therapies for Alzheimer's disease

J Zheng - Animal Models and Experimental Medicine, 2022 - Wiley Online Library
Adult hippocampal neurogenesis (AHN) facilitates hippocampal circuits plasticity and
regulates hippocampus‐dependent cognition and emotion. However, AHN malfunction has …

p38 inhibition decreases Tau toxicity in microglia and improves their phagocytic function

JR Perea, M Bolós, R Cuadros, E García… - Molecular …, 2022 - Springer
Alzheimer's disease (AD) and other tauopathies are histopathologically characterized by tau
aggregation, along with a chronic inflammatory response driven by microglia. Over the past …